Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
MOB1A/B Loss Rewires Intestinal Epithelial Signaling
2026-08-14
The reference study shows that intestinal epithelial depletion of MOB1A/B disrupts the balance among Hippo, Wnt, and BMP/TGF-β signaling, producing transient hyperproliferation followed by stem-cell loss, secretory-lineage defects, and epithelial degeneration. Pharmacological inhibition of BMP or TGF-β signaling partially restored differentiation but did not recover the intestinal stem-cell pool, revealing a pathway-specific but incomplete rescue strategy.
-
SB-505124 hydrochloride for Reliable Cell Assays
2026-08-13
A scenario-based guide to using SB-505124 hydrochloride (SKU A3799) in viability, proliferation, cytotoxicity, and fibrosis-related assays. It connects pathway-specific controls, solvent handling, assay interpretation, and vendor selection to documented biochemical and formulation data.
-
Dexamethasone (DHAP) for Reliable Cell Assays
2026-08-13
This scenario-driven guide explains how Dexamethasone (DHAP), SKU A2324, can improve experimental control in viability, proliferation, cytotoxicity, inflammation, and differentiation studies. It combines formulation-aware handling, assay controls, model selection, and evidence-based interpretation to support more reproducible laboratory decisions.
-
Z-IETD-FMK and the Cell-Death Decision Point
2026-08-12
Z-IETD-FMK is a selective caspase-8 probe for separating apoptotic, immune-signaling, and pyroptotic outcomes. This article connects T cell and TRAIL assays with new mechanistic insights from chicken GSDME research.
-
L. plantarum P101 and AMPK in Alcoholic Steatosis
2026-08-12
The reference study links Lactiplantibacillus plantarum P101 to reduced alcohol-induced hepatic lipid accumulation through AMPK activation, supported by pharmacological inhibition, gut microbiota profiling, and serum metabolomics. Its main practical contribution is a layered framework for distinguishing probiotic-associated protection from AMPK-dependent mechanism in experimental alcoholic fatty liver disease.
-
BMS-345541: IKK-1/IKK-2 Inhibition Workflows
2026-08-11
BMS-345541 connects selective IKK-1/IKK-2 inhibition with practical workflows for inflammation research, vascular signaling, and cancer research. This guide translates NF-κB pathway evidence into dosing, assay-selection, and troubleshooting decisions for reproducible cytokine suppression and apoptosis studies.
-
AICAR Phosphate: AMPK Assay Design
2026-08-11
AICAR phosphate (Acadesine) is an AMPK-activating research reagent for dissecting apoptosis, B-CLL selectivity, and mitochondrial signaling. This guide translates hypoxia–choroid plexus findings into a rigorous framework for choosing cellular readouts, controls, and interpretation limits.
-
Verbascoside PKC/NF-κB Inhibition Workflow
2026-08-10
Verbascoside offers a practical way to interrogate PKC/NF-κB signaling across osteoclast differentiation, inflammatory responses, and bone-cell assays. This workflow emphasizes concentration anchoring, pathway-resolved readouts, solvent control, and careful translation of findings from osteoclastogenesis research to osteonecrosis models.
-
SB525334: Mapping TGF-β1 in Tissue Repair
2026-08-09
The TGF-β1 pathway can drive fibrosis while also supporting angiogenesis, immune coordination, and tissue repair. This thought-leadership article positions SB525334 as a precise pharmacological tool for testing when ALK5 signaling is beneficial, excessive, or context-dependent across fibrosis and wound-healing models.
-
Cell Integrity Sets Ploidy Limits in Budding Yeast
2026-08-08
Barker, Murray, and Bell show that budding yeast can undergo repeated genome duplication to reach approximately 32–64C, but further expansion is constrained by cell-surface integrity rather than chromosome content alone. Their two-route endoreplication design connects ploidy-dependent growth with physical surface stress and repression of ergosterol-biosynthesis genes, providing a useful framework for fungal membrane and antifungal mechanism studies.
-
Chlorambucil Workflows for DNA Damage Assays
2026-08-07
Use Chlorambucil as a controlled DNA-crosslinking stressor to compare growth inhibition with genuine cell killing. This workflow combines solvent and dosing discipline with orthogonal viability, apoptosis, and DNA-damage readouts for more interpretable cancer-cell experiments.
-
DMH-1 (SKU B3686): Precision ALK2 Inhibition for Reliable As
2026-08-07
This article addresses key laboratory challenges in cell-based assays and organoid research, illustrating how DMH-1 (SKU B3686) offers reproducibility and pathway specificity as a selective ALK2 inhibitor. Drawing on recent literature and real-world scenarios, we highlight workflow, data interpretation, and vendor selection considerations to optimize experimental outcomes with DMH-1.
-
Romidepsin (FK228) Protocols: HDAC Inhibition in Cancer Mode
2026-08-06
Romidepsin (FK228) stands as a gold-standard HDAC inhibitor for cancer epigenetics, enabling precise modulation of chromatin and synergistic therapy design. This guide decodes hands-on workflows, troubleshooting strategies, and the latest insights from hepatocellular carcinoma research, empowering researchers to optimize Romidepsin-based experiments.
-
SB525334: Targeting TGF-beta1 Receptor in Fibrosis and Wound
2026-08-06
Explore SB525334, a potent TGF-beta1 receptor inhibitor, and its pivotal role in modulating fibrosis and advanced wound healing research. This article offers a unique, mechanistic perspective and practical guidance for leveraging SB525334 in translational and disease-relevant models.
-
BX795: Dissecting Kinase Signaling and Autophagy in Immunity
2026-08-05
Explore how BX795, a leading PDK1 inhibitor, uniquely enables researchers to probe the interplay between innate immune signaling, TBK1-mediated autophagy, and cancer cell growth. This article reveals new mechanistic insights, grounded in recent literature, and highlights distinct applications beyond traditional oncology assays.